Skip to main content
. Author manuscript; available in PMC: 2013 Sep 19.
Published in final edited form as: Ther Drug Monit. 2012 Apr;34(2):176–181. doi: 10.1097/FTD.0b013e31824d6a4e

Table 2.

The final parameter estimates and 95% CI from NONMEM and the bootstrap analyses§

Parameter NONMEM Bootstrap Analysis

Estimate 95% CI* Median 95% CI

CL/F (L/hr) 3.59 [3.39–3.79] 3.58 [3.39–3.80]
If taking PHT 1.23 [0.961–1.50] 1.26 [0.963–1.50]
V/F (L) 102 [37.1–167] 92.1 [19–189.6]
Ka (hr−1) 0.197 [0.0933–0.301] 0.19 [0.03–0.314]
IIV of CL/F (%CV) 18.1 [12.37–22.34] 17.92 [13.02–22.98]
IIV of V/F (%CV) 74.7 [21.1–103.44] 77.84 [1.06–121.24]
RUV, proportional (%CV) 25.1 [21.47–28.2] 24.6 [21.74–28.68]
§

From 747 bootstrap runs with a successful minimization and successful covariance step

*

(Estimate) ± 1.96 × (standard error of the estimate)

2.5th and 97.5th percentile of the ranked bootstrap parameter estimates